vancomycin has been researched along with adenosine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bandur, N; Finking, R; Koert, U; Marahiel, MA; May, JJ; Weber, TT; Wiegeshoff, F | 1 |
| Cristalli, G; Lambertucci, C; Petrelli, D; Prenna, M; Vitali, LA; Volpini, R | 1 |
| Beppler, C; Kang, TM; Miller, JH; Yuan, J; Zhou, A | 1 |
| Goffin, E; Jacques, N; Lancellotti, P; Musumeci, L; Oury, C; Pirotte, B; Servais, L | 1 |
1 review(s) available for vancomycin and adenosine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for vancomycin and adenosine
| Article | Year |
|---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Inhibition of the D-alanine:D-alanyl carrier protein ligase from Bacillus subtilis increases the bacterium's susceptibility to antibiotics that target the cell wall.
Topics: Adenosine; Alanine; Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; Base Sequence; Carbon-Oxygen Ligases; Carrier Proteins; Cell Wall; Cloning, Molecular; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli Proteins; Growth Inhibitors; Microbial Sensitivity Tests; Molecular Sequence Data; Protein Processing, Post-Translational; Substrate Specificity; Transferases; Transferases (Other Substituted Phosphate Groups); Vancomycin | 2005 |
In vitro antibacterial activity of different adenosine analogues.
Topics: Adenosine; Anti-Bacterial Agents; Dimethyl Sulfoxide; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Vancomycin | 2012 |
Deoxycytidine deaminase-deficient Escherichia coli strains display acute sensitivity to cytidine, adenosine, and guanosine and increased sensitivity to a range of antibiotics, including vancomycin.
Topics: Adenosine; Anti-Bacterial Agents; Cytidine; Cytidine Deaminase; Drug Resistance, Bacterial; Escherichia coli; Gene Deletion; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Guanosine; Nucleoside Deaminases; Vancomycin | 2014 |
Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria.
Topics: Adenosine; Animals; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Prosthesis-Related Infections; Pseudomonas aeruginosa; Purinergic P2Y Receptor Antagonists; Rifampin; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Ticagrelor; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |